|
|
| | | | | | Dear colleagues,
| | | | | | | | The countdown has begun! The 14th International Symposium on Hodgkin Lymphoma, ISHL14, is almost here — in just two weeks, we can't wait to welcome you to Cologne, Germany, for what promises to be an inspiring gathering of our community.
| | | | | |
|
| | | | | | We are especially excited about the opening ceremony, where we will celebrate excellence in our field with five Abstract Awards and the prestigious Karl-Musshoff Prizes.
| | | | | | | | This year, the Karl-Musshoff Prizes will be awarded to:
- Judith Trotmann, Sydney (Australia – represented by Nicole Wong Doo) for the clinical topic:
The MyHodgkin MyHealth App: patient-derived data for tracking Hodgkin Lymphoma survivorship (T093) and - Wolfram Klapper, Kiel (Germany) for the preclinical topic:
Artificial intelligence predicts EBV status and reveals prognostic morphology phenotypes in advanced-stage classic Hodgkin (T047).
| | | | | |
|
| | | | | | Bringing our community together on this scale takes committed sponsors. Our sincere thanks go to the pharmaceutical companies:
| | | | | |
|
 |
| | | | | | ISHL14 will take place from October 03 to 05, 2026 in Cologne, Germany. Please visit our website for further information.
| | | | | |
|
| | Best regards,
| | | | | | | | Peter Borchmann, MD,
Symposium Chairman | |
Paul J. Bröckelmann, MD,
Symposium Co-Chair | |
Dennis Eichenauer, MD,
Symposium Co-Chair | |
Justin Ferdinandus, MD,
Symposium Co-Chair | |
| | | | |
|
|
|
